Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 27.54%1.76B | ---- | ---- | ---- | -71.40%1.38B | ---- | ---- |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | ---- | ---- | ---- | 58.56%-9.87M | ---- | ---- | ---- | 63.33%-23.81M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 3.66%-1.52B | ---- | ---- | ---- | 3.01%-1.58B | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -81.41%88.54M | ---- | ---- | ---- | -39.38%476.23M | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 23.27%310.19M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -88.68%3.81M | ---- | ---- | ---- | -90.48%33.64M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | -60.49%52.62M | ---- | ---- | ---- | 10.11%133.19M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | 4,164.18%32.11M | ---- | ---- | ---- | -101.33%-790K | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | 352.15%170.24M | ---- | ---- | ---- | -106.77%-67.52M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | 352.15%170.24M | ---- | ---- | ---- | -106.77%-67.52M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -365.99%-377.65M | ---- | ---- | ---- | 46.97%-81.04M | ---- | ---- |
| -Available for sale investment sale loss (gain) | ---- | ---- | ---- | -136.12%-135.88M | ---- | ---- | ---- | -2,661.28%-57.55M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---217.93M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -0.74%-23.67M | ---- | ---- | ---- | 60.13%-23.5M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---172K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 9.68%2.78B | ---- | ---- | ---- | 9.13%2.53B | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | 18.12%30.25M | ---- | ---- | ---- | 64.75%25.61M | ---- | ---- |
| Financial expense | ---- | ---- | ---- | 1.33%4.22B | ---- | ---- | ---- | 50.59%4.17B | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | -52.30%-355.88M | ---- | ---- | ---- | 79.67%-233.67M | ---- | ---- |
| Special items | ---- | ---- | ---- | 19.73%-15.5M | ---- | ---- | ---- | -380.77%-19.31M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 2.86%6.74B | ---- | ---- | ---- | -24.77%6.56B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -60.66%738.74M | ---- | ---- | ---- | -36.29%1.88B | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | 35.34%-807.1M | ---- | ---- | ---- | -247.29%-1.25B | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 323.12%432.92M | ---- | ---- | ---- | -257.00%-194.03M | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | 60.31%-423.91M | ---- | ---- | ---- | -207.80%-1.07B | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 113.95%34.66M | ---- | ---- | ---- | 74.87%-248.5M | ---- | ---- |
| Cash from business operations | ---- | 299.25%1.6B | ---- | 18.39%6.72B | ---- | -89.02%400.45M | ---- | -54.44%5.67B | ---- | -33.54%3.65B |
| Other taxs | ---- | -1,389.34%-312.97M | ---- | 96.08%-14.14M | ---- | 86.77%-21.01M | ---- | 71.01%-360.34M | ---- | 78.49%-158.8M |
| Adjustment items of business operations | -38.96%2.63B | ---- | 41.20%501.93M | ---- | -18.96%4.31B | ---- | 39.99%355.47M | ---- | -34.41%5.32B | ---- |
| Net cash from operations | -38.96%2.63B | 238.87%1.29B | 41.20%501.93M | 26.15%6.7B | -18.96%4.31B | -89.12%379.43M | 39.99%355.47M | -52.60%5.31B | -34.41%5.32B | -26.55%3.49B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 41.76%621.26M | 36.83%416.52M | --75.3M | 48.01%593.27M | 19.42%438.26M | 41.91%304.42M | ---- | -25.55%400.84M | -21.59%366.98M | -22.36%214.52M |
| Decrease in deposits (increase) | ---- | ---- | ---- | 5.77%-817K | ---- | ---- | ---- | ---867K | ---- | ---- |
| Sale of fixed assets | -19.88%75.86M | -33.22%51.4M | -27.81%25.87M | 162.60%242.83M | 64.48%94.68M | 104.75%76.98M | 533.63%35.84M | -85.57%92.47M | -89.69%57.56M | 52.36%37.6M |
| Purchase of fixed assets | 11.86%-4.39B | -23.91%-2.39B | -108.47%-1.75B | -107.86%-7.65B | -35.35%-4.98B | 11.78%-1.93B | -19.35%-838.01M | 46.16%-3.68B | 53.27%-3.68B | -9.40%-2.18B |
| Purchase of intangible assets | ---- | -63.22%-1.88M | ---- | -8.22%-50.96M | ---- | 86.95%-1.15M | ---- | -2.08%-47.09M | ---- | -657.78%-8.81M |
| Sale of subsidiaries | ---- | -100.00%6K | ---- | 228.25%288.04M | --246.32M | --256.94M | --245.99M | -94.02%87.75M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 121.57%647K | ---- | ---- | ---- | ---3M |
| Recovery of cash from investments | -50.09%2.8B | -84.42%110.84M | -38.14%1.01B | 58.09%1.04B | 1.20%5.61B | 48.33%711.58M | -15.67%1.63B | -68.21%655.86M | -40.88%5.54B | -57.35%479.73M |
| Cash on investment | -209.94%-11M | -257.26%-11.02M | ---6M | 96.52%-10.56M | -18.30%-3.55M | 93.86%-3.08M | ---- | 84.27%-303.38M | 97.89%-3M | 70.80%-50.21M |
| Other items in the investment business | 1,641.99%50.28M | 12.75%1.32B | 59.08%-1.22M | -35.20%2.43B | 96.87%-3.26M | -63.91%1.17B | 98.80%-2.99M | -1.06%3.76B | -221.60%-104.32M | 966.99%3.24B |
| Net cash from investment operations | -160.63%-851.71M | -185.79%-504.29M | -160.66%-647.16M | -423.37%-3.11B | -35.66%1.4B | -65.90%587.81M | 7.85%1.07B | 420.20%962.73M | -7.40%2.18B | 10,882.30%1.72B |
| Net cash before financing | -68.85%1.78B | -19.20%781.51M | -110.21%-145.23M | -42.79%3.59B | -23.82%5.72B | -81.44%967.25M | 14.41%1.42B | -42.48%6.28B | -28.33%7.51B | 9.40%5.21B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 44.01%48.85B | 34.50%22.11B | 22.63%9.55B | -8.70%41.27B | -1.37%33.92B | -24.31%16.44B | -26.96%7.79B | -12.66%45.2B | -22.07%34.4B | 27.62%21.72B |
| Refund | -14.12%-43.23B | -4.59%-22.37B | 31.28%-6.09B | 1.34%-48.2B | 13.12%-37.88B | 33.81%-21.39B | 50.02%-8.86B | 11.04%-48.85B | 9.49%-43.6B | -19.65%-32.31B |
| Issuance of bonds | ---- | 95.00%3.9B | ---- | --4B | ---- | --2B | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 12.01%-1.88B | ---- | -5.70%-4.32B | ---- | -2.48%-2.13B | ---- | -57.09%-4.09B | ---- | -110.23%-2.08B |
| Dividends paid - financing | 7.21%-3.34B | ---- | 14.85%-943.41M | 41.38%-690.91M | 14.40%-3.6B | ---- | -8.84%-1.11B | 64.11%-1.18B | 14.73%-4.21B | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---212.26M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -189.97%-363.99M | -586.73%-307.44M | -539.02%-118.02M | -144.34%-20.62M | -251.60%-125.53M | -1,036.57%-44.77M | 32.04%-18.47M | 100.95%46.5M | 99.29%-35.7M | 100.10%4.78M |
| Net cash from financing operations | 124.97%1.92B | 127.13%1.4B | 208.59%2.39B | 7.11%-8.29B | 42.87%-7.69B | 59.40%-5.15B | 72.85%-2.21B | 38.40%-8.93B | 4.18%-13.45B | -37.85%-12.7B |
| Effect of rate | -57.37%73.73M | -60.58%67.12M | 2.99%75.11M | 52.30%355.88M | -29.49%172.96M | 31.97%170.27M | 183.00%72.93M | -79.67%233.67M | -76.50%245.29M | -81.88%129.02M |
| Net Cash | 288.06%3.7B | 152.07%2.18B | 387.37%2.25B | -77.40%-4.7B | 66.91%-1.97B | 44.06%-4.19B | 88.62%-782.78M | 25.96%-2.65B | -66.72%-5.95B | -68.32%-7.48B |
| Begining period cash | -33.37%8.68B | -33.37%8.68B | -33.37%8.68B | -15.65%13.02B | -15.65%13.02B | -15.65%13.02B | -15.65%13.02B | -13.60%15.44B | -13.60%15.44B | -13.60%15.44B |
| Cash at the end | 10.88%12.45B | 21.28%10.92B | -10.65%11B | -33.37%8.68B | 15.29%11.23B | 11.40%9.01B | 45.32%12.31B | -15.65%13.02B | -36.54%9.74B | -42.80%8.09B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited, Shin-Ei Zhonghe Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinewing Zhonghe (Hong Kong) Certified Public Accountants Limited, Shinewing Zhonghe Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.